Notable Downgrades: Baidu (BIDU), TripAdvisor (TRIP), PTC Therapeutics (PTCT), InvenSense (INVN), Keryx Biopharmaceuticals (KERX)

Analysts at JP Morgan (JPM) downgraded Baidu, Inc. (BIDU) from ‘Overweight‘ to ‘Neutral‘ in a research report issued to clients on Tuesday. The target price for BIDU is lowered from $240 to $215. On valuation measures, Baidu Inc. ADS stock it’s trading at a forward P/E multiple of 3.29x, and at a multiple of 32.23x […] View the full post at: Notable Downgrades: Baidu (BIDU), TripAdvisor (TRIP), PTC Therapeutics (PTCT), InvenSense (INVN), Keryx Biopharmaceuticals (KERX) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock